Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | NEK2 | P51955 | 1/20 | 0.38 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.37 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | HTR6 | P50406 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29827543 | 1.00 | PAX8 (0.41) | PAX8HPRT1CHEK1NEK2LIMK1 | |
| Acetonitrile SCHEMBL28781302 | 0.92 | PAX8 (0.36) | PAX8HPRT1CHEK1NEK2LIMK1 | |
| SCHEMBL2964374 | 0.84 | CHEK1 (0.39) | HPRT1CHEK1NEK2LIMK1DYRK1A | |
| SCHEMBL726452 | 0.83 | CA2 (0.47) | CHEK1NEK2LIMK1DYRK1ACLK4 | |
| SCHEMBL30502409 | 0.83 | CYP2D6 (0.43) | CHEK1NEK2LIMK1DYRK1ACLK4 | |
| SCHEMBL2679932 | 0.83 | CYP2D6 (0.43) | CHEK1NEK2LIMK1DYRK1ACLK4 | |
| SCHEMBL29773602 | 0.83 | CA2 (0.47) | CHEK1NEK2LIMK1DYRK1ACLK4 | |
| SCHEMBL5608087 | 0.83 | SIGMAR1 (0.40) | HPRT1CHEK1NEK2LIMK1DYRK1A | |
| SCHEMBL29827269 | 0.82 | PAX8 (0.38) | PAX8HPRT1TDP1ALDH1A1CYP2A6 | |
| Hydrochloric Acid SCHEMBL28101819 | 0.81 | EP300 (0.43) | CHEK1NEK2LIMK1DYRK1ACLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117607117-A | Visual research method for reaction property of lipase at oil-water interface | 四川大学 | 2024-02-27 | — | — | CN | claimed |
| CN-113527514-B | Application of Gstp1 in preparation of synergistic CAR-T | 徐州医科大学 | 2022-07-15 | — | — | CN | claimed |
| CN-108760950-B | Method for determining nitrofuran metabolite | 国检测试控股集团京诚检测有限公司 | 2022-07-15 | — | — | CN | claimed |
| CN-113527514-A | Application of Gstp1 in preparation of synergistic CAR-T | 徐州医科大学 | 2021-10-22 | — | — | CN | claimed |
| CN-113402618-A | Application of Ski in preparation of synergistic CAR-T cells | 徐州医科大学 | 2021-09-17 | — | — | CN | claimed |
| US-20170027876-A1 | PROTEIN-BASED ENTERIC COATING FOR ORAL DOSAGE FORMS | 9286-3620 QUEBEC INC. (CA) | 2017-02-02 | — | — | US | claimed |
| EP-3082777-A1 | PROTEIN-BASED ENTERIC COATING FOR ORAL DOSAGE FORMS | 9286-3620 Québec Inc. (CA) | 2016-10-26 | — | — | EP | claimed |
| WO-2015089674-A1 | PROTEIN-BASED ENTERIC COATING FOR ORAL DOSAGE FORMS | 9286-3620 QUÉBEC INC. (CA) | 2015-06-25 | — | — | WO | claimed |
| CN-104678028-A | Pretreatment and detection method for biogen amine neurotransmitter and detection kit | INST PHARM & TOXICOLOGY AMMS | 2015-06-03 | — | — | CN | claimed |
| WO-1989008835-A1 | THIOACYLATION PEPTIDE SEQUENCING WITH ACYLATION OF THIAZOLINES | BIO-AFFINITY SYSTEMS, INC. (US) | 1989-09-21 | — | — | WO | claimed |
| CN-116875690-B | Gene mutation for diagnosing multiple epiphyseal dysplasia | BEIJING RESEARCH INSTITUTE OF TRAUMATOLOGY AND ORTHOPAEDICS (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-119301272-A | Electrophoresis mediated characterization of the DNA content of adeno-associated viral capsids | 瑞孚迪健康科学公司 | 2025-01-10 | — | — | CN | disclosed |
| US-20240209094-A1 | NEW STABLE ANTI-VISTA ANTIBODY | PIERRE FABRE MEDICAMENT (FR) | 2024-06-27 | — | — | US | disclosed |
| WO-2024121380-A1 | VACCINAL COMPOSITION AND ADJUVANT | PIERRE FABRE MEDICAMENT (FR) | 2024-06-13 | — | — | WO | disclosed |
| US-20240158503-A1 | ANTI-VSIG4 ANTIBODY OR ANTIGEN BINDING FRAGMENT AND USES THEREOF | PIERRE FABRE MEDICAMENT (FR) | 2024-05-16 | — | — | US | disclosed |
| WO-1990013818-A1 | GLYCOSYLATED HAEMOGLOBIN ASSAY | AXIS RESEARCH AS (NO) | 1990-11-15 | — | — | WO | disclosed |
| US-4968696-A | CHRONIC UREMIA OR HEPATIC CIRRHOSIS | PFRIMMER + CO. PHARMAZEUTISCHE WERKE ERLANGEN GMBH + CO. KG (DE) | 1990-11-06 | — | — | US | disclosed |
| US-4396528-A | Fluorescent composition, a process for synthesizing the fluorescent composition | VARIAN ASSOCIATES, INC. (US) | 1983-08-02 | — | — | US | disclosed |
| US-4275300-A | Fluorescent composition, a process for synthesizing the fluorescent composition, and methods of use of the fluorescent composition | VARIAN ASSOCIATES, INC. (US) | 1981-06-23 | — | — | US | disclosed |
| US-4231750-A | Methods for performing chemical assays using fluorescence and photon counting | DIAGNOSTIC REAGENTS, INC. (US) | 1980-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170027876-A1 | PROTEIN-BASED ENTERIC COATING FOR ORAL DOSAGE FORMS | FABP2, FABP6, CUTA | PAX8 2369/4885HPRT1 3950/4885CHEK1 3926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.